Llwytho...
Risk of using hydroxychloroquine as a treatment of COVID-19
The emerging COVID-19 pandemic poses a threat to the global health care system. Given the lack of antiviral therapies or vaccines for the disease, the antimalarial drug hydroxychloroquine (HCQ) obtained much attention as a treatment for COVID-19. However, there are limited and uncertain clinical dat...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Int J Risk Saf Med |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
IOS Press
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7504983/ https://ncbi.nlm.nih.gov/pubmed/32474476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JRS-200024 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|